FIELD: medicine, oncology. SUBSTANCE: composition has, wt.-%: 9-(2-chloroethyl)-7-nitroso-L-homocitrulline 0.6-0.95; 9-(2-chloroethyl)-9-nitroso-L-homocitrulline 0.05-0.4; dextran (molecular mass is 40000) or polyglucine (molecular mass is 60000) or polyvinylpyrrolidone (molecular mass is 12600) 0.5-2.0; citric acid or sorbic acid 0.025-0.1; water for injection or 5%-th glucose solution or isotonic sodium chloride solution up to 100. EFFECT: enhanced activity, decreased by-side effects. 4 dwg, 14 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREPARING N-(2-CHLOROETHYL)-N-NITROSO-L-HOMOCITRULLINE OR N-(2-CHLOROETHYL)-N-NITROSO-L-HOMOCITRULLINE FOR INJECTIONS | 1995 |
|
RU2111742C1 |
N-NITROSO-N-[(2-CHLOROETHYL)CARBAMOYL]-L- ORNITHINE | 2012 |
|
RU2503657C1 |
ANTI-TUMOUR PREPARATION | 2014 |
|
RU2569729C1 |
ANTIMALIGNANT AGENT | 1989 |
|
SU1683190A1 |
ANTITUMOR AGENT | 1996 |
|
RU2093158C1 |
13-(1-OXYL-2,2,6,6-TETRAMETHYLPIPERYLIDENYL-4)HYDRAZONE OF CHLORINE-HYDRATE RUBOMICIN WITH PARAMAGNETIC CENTER POSSESSING ANTITUMORAL ACTIVITY AND METHOD OF OBTAINING THE SAME | 1980 |
|
SU977462A1 |
NITROXYL DERIVATIVES OF NITROSOUREA SHOWING ANTITUMOR AND MUTAGENIC ACTIVITY | 0 |
|
SU1259650A1 |
ANTITUMOUR ANTHRAFURANDIONE AND BASED PHARMACEUTICAL COMPOSITIONS | 2014 |
|
RU2554939C1 |
ANTITUMOR AGENT | 1999 |
|
RU2144821C1 |
STEROID ETHERS OF N-DI(2-CHLOR-ETHYL)-AMINOPHENYL-N- ACETYLALANINE HAVING ANTITURMORIGENIC, ANDROGENOUS, AND ANABOLIC ACTIVITY | 1984 |
|
SU1266111A1 |
Authors
Dates
1996-10-27—Published
1980-10-24—Filed